Back to search results

Promoting Well-being and Health in Heart Failure

This study is testing two different phone-based programs to help people with heart failure (HF) improve their health habits. One program, called PP-MI, combines "Positive Psychology" (focusing on strengths and well-being) with "Motivational Interviewing" (helping you find your own reasons to change). The other program, MI-alone, focuses on education about heart failure and sticking to healthy habits. Both programs last 12 weeks, with additional text messages for a total of 24 weeks. Researchers want to see if these programs help you better follow recommendations for diet, exercise, and medications. You might be able to join if you are an adult with NYHA Class I, II, or III heart failure and have trouble sticking to health behaviors. The study plans to enroll 280 participants, but its current status is unclear.

Study design
This is an interventional study comparing two behavioral programs in 280 participants with heart failure. Participants will be randomly assigned to one of the two programs.
What's involved
You will participate in a 12-week phone-delivered intervention, with additional text messages for a total of 24 weeks. You will also have two study visits, which can be in-person or virtual.
Compensation
Not stated in the trial record.
Follow-up
Your health behavior adherence will be measured at 12 weeks, 24 weeks, and 48 weeks after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04829617

Promoting Well-being and Health in Heart Failure

Recruiting
NAAges 18+InterventionalTreatment
Massachusetts General Hospital
~280 participants
Updated 2026-04-14 on ClinicalTrials.gov
What's tested:PP-MI InterventionMI-alone Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Health behavior adherence
Measured over Baseline, 12 Weeks, 24 Weeks, 48 Weeks

Conditions

Heart Failure
Heart Failure NYHA Class I
Heart Failure NYHA Class II
Heart Failure NYHA Class III

Explore related trials

Heart Failure

NCT04829617

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Massachusetts General Hospital

    Boston, Massachusettsstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Christopher M Celano, MD · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Who to contact

Christohper M Celano, MD
[email protected]
617-726-6485
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adult patients with NYHA class I, II, or III HF.
Suboptimal adherence to health behaviors. This will be defined as a total score of ≤15 on three Medical Outcomes Study Specific Adherence Scale (MOS) items regarding diet/exercise/medications.

Exclusion

Cognitive deficits impeding a participant's ability to provide informed consent or participate, assessed via a 6-item cognitive test.
Medical conditions likely to lead to death within 6 months.
Inability to participate in physical activity due to another medical condition (e.g., arthritis).
Inability to read, write, or speak in English.
Current participation in another intervention or program that has been designed to promote well-being or health behavior adherence.

What this trial measures

  • Health behavior adherenceBaseline, 12 Weeks, 24 Weeks, 48 Weeks

    Composite score of overall activity (measured by accelerometer in steps/day), sodium excretion (urine sodium in mEq/day), and medication adherence (Medication Event Monitoring System \[MEMS\] electronic pill bottle). This composite score will be created by calculating z scores for each individual outcome measure and then averaging them for each participant at each time point.